Menu

德国拜耳利伐沙班贵不贵?多少钱

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

Is Bayer expensive in Germany? How much does it cost? Rivaroxaban is an oral drug produced by Bayer in Germany. It was approved for marketing in the EU in September 2008 and entered my country in 2009. It is used to treat deep vein thrombosis and pulmonary embolism in adults to reduce the risk of recurrence. Rivaroxaban has been on the market at home and abroad for many years, and the current price is relatively low. It is understood that rivaroxaban produced by Bayer of Germany and listed in Turkey is currently the most cost-effective. The specifications are 20mg*28 tablets and 15mg*28 tablets, and the prices are around 350$.

Rivaroxaban is a highly bioavailable coagulation factor inhibitor that can also prevent venous thrombosis in adult patients undergoing elective hip or knee replacement surgery, and can be used in patients with non-valvular atrial fibrillation to reduce the risk of stroke and systemic embolism. For different conditions, the dosage and duration of treatment of rivaroxaban are not exactly the same.

Rivaroxaban is used to prevent venous thrombosis (VTE) in adult patients undergoing elective hip or knee replacement surgery. The recommended dose is 10 mg, taken orally, once daily. Treatment time is 35 days for hip replacement patients and 12 days for knee replacement patients. The recommended dose for the treatment of DVT (venous thrombosis) is 15 mg twice a day for the first three weeks, and then 20 mg once a day for maintenance treatment and to reduce the risk of DVT recurrence and PE. The recommended dose for the treatment of adult patients with non-valvular atrial fibrillation is 20 mg/day/time.

It can be taken with or without food. If the patient misses a dose, he should take it immediately and resume normal medication the next day. Rivaroxaban is contraindicated if you are allergic to rivaroxaban or any of the excipients in the tablets, and patients with clinically significant active bleeding should not be treated with rivaroxaban.

Recommended related hot articles: /newsDetail/90012.html

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。